| 8486992 |
Carboxamide derivatives as muscarinic receptor antagonists |
Paul Alan Glossop, Simon John Mantell, Christine WATSON |
2013-07-16 |
$331,538,000 |
| 8268881 |
Carboxamide derivatives as muscarinic receptor antagonists |
Paul Alan Glossop, Simon John Mantell, Christine WATSON |
2012-09-18 |
$330,831,000 |
| 7772223 |
Carboxamide derivatives as muscarinic receptor antagonists |
Paul Alan Glossop, Simon John Mantell, Christine WATSON |
2010-08-10 |
$126,194,000 |
| 7579471 |
Tropane derivatives useful in therapy |
Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor |
2009-08-25 |
$295,494,000 |
| 7576097 |
Tropane derivatives useful in therapy |
Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen |
2009-08-18 |
$206,216,000 |
| 7368460 |
Tropane derivatives useful in therapy |
Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen |
2008-05-06 |
$143,522,000 |
| 7217714 |
CCR5 modulators |
Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards |
2007-05-15 |
|
| 7217721 |
Tropane derivatives useful in therapy |
Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor |
2007-05-15 |
$412,808,000 |
| 7141585 |
Pyrazole derivatives |
Romuald CORBAU, Charles Eric Mowbray, Manoussos Perros, Paul Anthony Stupple |
2006-11-28 |
|
| 7041667 |
CCR5 modulators |
Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards |
2006-05-09 |
$303,797,000 |
| 6916927 |
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2005-07-12 |
$283,397,000 |
| 6855724 |
Tropane derivatives useful in therapy |
Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor |
2005-02-15 |
|
| 6750230 |
Pyrazole derivatives |
Romuald CORBAU, Charles Eric Mowbray, Manoussos Perros, Paul Anthony Stupple |
2004-06-15 |
$361,830,000 |
| 6723719 |
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2004-04-20 |
$379,600,000 |
| 6670366 |
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2003-12-30 |
$236,324,000 |
| 6667314 |
Tropane derivatives useful in therapy |
Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen |
2003-12-23 |
$199,934,000 |
| 6656945 |
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction |
Simon F. Campbell, Alexander Roderick MacKenzie |
2003-12-02 |
$301,389,000 |
| 6586430 |
CCR5 modulators |
Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards |
2003-07-01 |
$274,146,000 |
| 6458951 |
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2002-10-01 |
$404,760,000 |
| 6407114 |
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2002-06-18 |
$368,716,000 |
| 6333330 |
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Graham Nigel Maw, David James Rawson, Stephen Derek Albert Street |
2001-12-25 |
|
| 6300335 |
4-aminoquinazoline derivative cGMP-PDE inhibitors for the treatment of erectile dysfunction |
Simon F. Campbell, Alexander Roderick MacKenzie |
2001-10-09 |
$572,735,000 |
| 6251904 |
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street |
2001-06-26 |
$895,190,000 |
| 5977142 |
Oxa-and thia-diazole muscarinic receptor antagonists |
Robert J. Bass, Alexander Roderick MacKenzie |
1999-11-02 |
$198,583,000 |
